QURE - Gene Therapy Player UniQure To Lay Off 20% Of Workforce Stop Parkinson's Study | Benzinga
uniQure N.V. (NASDAQ: QURE) announced to cut about 20% of its total workforce, or about 114 jobs, and end investments in more than half of its research and technology projects to reduce costs.
UniQure expects to generate savings of about $180 million over the next three years through the restructuring.
The current balance of cash, cash equivalents, and investment securities of $628.6 million as of June 30, 2023 (excludes $100 million milestone ...